PBYI - Biotech Analysis Central Pharma News: AbbVie's Trouble Merck KGaA's Bad Streak Puma's Positive Data
Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry.
AbbVie And Roche Have Trouble With Venclexta As Partial Clinical Hold Is Placed
News: Recently, AbbVie (ABBV) and Roche (RHHBY) announced that the FDA had placed a partial clinical hold on Venclexta in all clinical trials dealing with treating patients with blood cancer known as multiple myeloma ((MM)). Specifically, the reason for the partial clinical hold is because of the data that was looked at from a Phase 3